BBS-Bioactive Bone Substitutes Oyj (HLSE:BONEHN0124) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BONEHN0124 Stock Overview

A biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland.

About the company

BONEHN0124 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Revenue is forecast to grow 86.7% per year

Risk Analysis

Has less than 1 year of cash runway

Does not have a meaningful market cap (€6M)

Shares are highly illiquid

Makes less than USD$1m in revenue (€0)

+ 2 more risks

BBS-Bioactive Bone Substitutes Oyj Competitors

Aptinyx

OTCPK:APTX

US$6.5m

PCI Biotech Holding

OB:PCIB

NOK 64.1m

Respiratorius

NGM:RESP

SEK 69.9m

Cyclerion Therapeutics

NasdaqCM:CYCN

US$6.0m

Price History & Performance

Summary of all time highs, changes and price drops for BBS-Bioactive Bone Substitutes Oyj
Historical stock prices
Current Share Price	€0.31
52 Week High	€0.31
52 Week Low	€0.26
Beta	-0.51
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.97%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BONEHN0124	FI Biotechs	FI Market
7D	4.7%	3.4%	0.5%
1Y	n/a	10.3%	9.3%

Return vs Industry: Insufficient data to determine how BONEHN0124 performed against the Finnish Biotechs industry.

Return vs Market: Insufficient data to determine how BONEHN0124 performed against the Finnish Market.

Price Volatility

Is BONEHN0124's price volatile compared to industry and market?
BONEHN0124 volatility
BONEHN0124 Average Weekly Movement	n/a
Biotechs Industry Average Movement	7.9%
Market Average Movement	4.1%
10% most volatile stocks in FI Market	6.3%
10% least volatile stocks in FI Market	2.5%

Stable Share Price: BONEHN0124 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BONEHN0124's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	24	Juliusz Rakowskias	www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.

BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary

How do BBS-Bioactive Bone Substitutes Oyj's earnings and revenue compare to its market cap?
BONEHN0124 fundamental statistics
Market cap	€6.29m
Earnings (TTM)	-€3.56m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-1.8x

P/E Ratio

Is BONEHN0124 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BONEHN0124 income statement (TTM)
Revenue	€0
Cost of Revenue	€15.62k
Gross Profit	-€15.62k
Other Expenses	€3.54m
Earnings	-€3.56m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 21, 2025

Earnings per share (EPS)	-0.18
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	147.1%

How did BONEHN0124 perform over the long term?

See historical performance and comparison